Kura Oncology Inc’s filing revealed that its SVP, Finance & Accounting DOYLE THOMAS JAMES unloaded Company’s shares for reported $38958.0 on Jan 28 ’25. In the deal valued at $7.87 per share,4,949 shares were sold. As a result of this transaction, DOYLE THOMAS JAMES now holds 88,193 shares worth roughly $0.69 million.
Then, Leoni Mollie sold 4,963 shares, generating $39,068 in total proceeds. Upon selling the shares at $7.87, the Chief Medical Officer now owns 88,253 shares.
Before that, Bair Teresa Brophy sold 7,281 shares. Kura Oncology Inc shares valued at $57,315 were divested by the Chief Legal Officer at a price of $7.87 per share. As a result of the transaction, Bair Teresa Brophy now holds 107,948 shares, worth roughly $0.85 million.
BTIG Research downgraded its Kura Oncology Inc [KURA] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Stifel also remained covering KURA and has decreased its forecast on October 14, 2024 with a “Hold” recommendation from previously “Buy” rating. Mizuho started covering the stock on December 22, 2023. It rated KURA as “a Buy”.
Price Performance Review of KURA
On Tuesday, Kura Oncology Inc [NASDAQ:KURA] saw its stock unchanged to $7.88. Over the last five days, the stock has lost -1.31%. Kura Oncology Inc shares have fallen nearly -9.53% since the year began. Nevertheless, the stocks have fallen -59.78% over the past one year. While a 52-week high of $24.17 was reached on 02/05/25, a 52-week low of $6.98 was recorded on 01/13/25. SMA at 50 days reached $8.39, while 200 days put it at $16.35.
Levels Of Support And Resistance For KURA Stock
The 24-hour chart illustrates a support level at 7.64, which if violated will result in even more drops to 7.40. On the upside, there is a resistance level at 8.04. A further resistance level may holdings at 8.20. The Relative Strength Index (RSI) on the 14-day chart is 41.29, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.35, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 79.51%. Stochastics %K at 28.15% indicates the stock is a holding.
The most recent change occurred on August 11, 2023 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $31 price target.
